SCHEMBL314493

SCHEMBL314493

Cc1cccc(-c2nnc3n2-c2ccc(Cl)cc2NC[C@@H]3C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TP53 P04637 1/20 0.37
CNR1 P21554 2/20 0.37
TSHR P16473 1/20 0.37
AVPR1A P37288 1/20 0.36
BRD4 O60885 6/20 0.35
LMNA P02545 1/20 0.34
GABRA1 P14867 1/20 0.34
HPGD P15428 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
OPRK1 P41145 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
MDM2 Q00987 1/20 0.34
NISCH Q9Y2I1 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
BRDT Q58F21 1/20 0.34
CREBBP Q92793 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314491 1.00 ALDH1A1 (0.41) ALDH1A1TP53CNR1TSHRAVPR1A
SCHEMBL314492 1.00 ALDH1A1 (0.41) ALDH1A1TP53CNR1TSHRAVPR1A
SCHEMBL315184 0.94 TP53 (0.43) ALDH1A1TP53CNR1AVPR1ABRD4
SCHEMBL315182 0.94 TP53 (0.43) ALDH1A1TP53CNR1AVPR1ABRD4
SCHEMBL315183 0.94 TP53 (0.43) ALDH1A1TP53CNR1AVPR1ABRD4
SCHEMBL314677 0.91 HSD11B1 (0.41) TP53CNR1AVPR1ABRD4LMNA
SCHEMBL314679 0.91 HSD11B1 (0.41) TP53CNR1AVPR1ABRD4LMNA
SCHEMBL314678 0.91 HSD11B1 (0.41) TP53CNR1AVPR1ABRD4LMNA
SCHEMBL314693 0.90 ALDH1A1 (0.36) ALDH1A1TP53CNR1AVPR1ABRD4
SCHEMBL313997 0.90 HSD11B1 (0.39) ALDH1A1TP53CNR1AVPR1ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US claimed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885TP53 293/4885CNR1 3936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.